Re: reply from Sarah

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 4799 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: reply from Sarah

in response to

Re: reply from Sarah

KOO-KOO2

posted on Nov 27, 2021 07:07PM

"Just saying, in the case that they're still some doubt that "ZHCLF" is not Zenith Capital Corp as we know it."